Brand Name :
Anafranil
Synonyms :
clomipramine
Class :
Antidepressants, TCAs
Dosage Forms & Strengths
capsule
25mg
50mg
75mg
25
mg
Orally
every day
Over the course of two weeks, gradually raise the dosage to 100 mg/day (divided up with meals)
Up to 250 mg/day may be increased further
once tolerated, may provide as a single daily dose of qHS
Dosage Forms & Strengths
capsule
25mg
50mg
75mg
25
mg
Orally
every day
Over the course of two weeks, gradually raise the dosage to 100 mg/day
Up to 250 mg/day may be increased further
once tolerated, may provide as a single daily dose of qHS
Age: ≥10 years
25 mg PO orally every day; gradually raise the dosage to 3 mg/kg/day or 100 mg/day
Up to 200 mg/day may be increased further
once tolerated, may provide as a single daily dose of qHS
Refer to adult dosing
may have an increased QTc-prolonging effect when combined with QT-prolonging agents
may have an increased QTc-prolonging effect when combined with QT-prolonging agents
may have an increased QTc-prolonging effect when combined with QT-prolonging agents
may have an increased QTc-prolonging effect when combined with QT-prolonging agents
may have an increased QTc-prolonging effect when combined with QT-prolonging agents
QTc-prolonging agents: they may increase the QTc-prolonging effect of clomipramine
QTc-prolonging agents: they may increase the QTc-prolonging effect of clomipramine
QTc-prolonging agents: they may increase the QTc-prolonging effect of clomipramine
QTc-prolonging agents: they may increase the QTc-prolonging effect of clomipramine
when both drugs are combined, there may be an increase in qtc interval
may increase the QTc prolonging effect of QT-prolonging Class III Antiarrhythmics
It may enhance QTc interval when combined with pentamidine
It may enhance QTc interval when combined with perphenazine
may increase the QT-prolonging effect and enhance the risk of ventricular arrhythmias
It may reduce the effects when combined with pleurisy root by an unspecified interactions mechanism
clomipramine: they may enhance the serum concentration of CYP1A2 Inhibitors
clomipramine: they may enhance the serum concentration of CYP1A2 Inhibitors
clomipramine: they may enhance the serum concentration of CYP1A2 Inhibitors
clomipramine: they may enhance the serum concentration of CYP1A2 Inhibitors
clomipramine: they may enhance the serum concentration of CYP1A2 Inhibitors
When clomipramine is used together with bromisoval, the risk or seriousness of CNS depression is enhanced
When clomipramine is used together with medazepam, the risk or seriousness of CNS depression is enhanced
Combining tegafur with clomipramine can reduce tegafur’s metabolism
when both drugs are combined, there may be an increased risk or severity of QTC prolongation
when used together, entrectinib and clomipramine both increase the QTc interval
CYP1A2 inhibitors increase the concentration of clomipramine in serum
it enhances by affecting the hepatic enzyme CYP2D6 metabolism
glycopyrrolate inhaled and formoterol
may decrease the toxic effects of each other by sedation
may increase the risk or severity of hypertension when combined
it increases the toxicity of atropine through an unknown mechanism
relugolix/estradiol/norethindrone
may increase the effect of each other by an unknown mechanism
Actions and Spectrum:
clomipramine is a tricyclic antidepressant medication that acts on the neurotransmitter’s serotonin and norepinephrine. It is primarily used to treat depression and obsessive-compulsive disorder (OCD).
In terms of its mechanism of action, clomipramine works by increasing the levels of serotonin and norepinephrine in the brain, which can help to elevate mood and reduce symptoms of anxiety and depression.
In terms of its spectrum of activity, clomipramine is classified as a tricyclic antidepressant, which means it has a broader range of activity compared to selective serotonin reuptake inhibitors (SSRIs), and is used to treat a range of psychiatric disorders, including depression, OCD, panic disorder, and eating disorders.
Frequency Defined
>10%
Headache (50-55%)
Xerostomia (84%)
Constipation (47%)
Fatigue (35-40%)
Ejaculation failure (42%)
Nausea (30-35%)
Weight gain (18%)
Impotence (20-25%)
1-10%
Hepatotoxicity (1-3%)
Weight loss (5%)
Frequency Not Defined
Blurred vision
Dyspepsia
Dizziness
Black Box Warning
The black box warning for clomipramine, an antidepressant medication, states that the drug has been associated with an increased risk of suicidal thoughts and behavior in children, adolescents, and young adults up to the age of 24.
Contraindication/Caution:
Contraindications:
Cautions:
Pregnancy warnings:
US FDA pregnancy category: C
Lactation:
Excreted into human milk is known
Pregnancy Categories:
Category A: Studies that were well-controlled and met expectations revealed no risk to the fetus in either the first or second trimester.
Category B: There were lack of studies on pregnant women and no evidence of risk to the foetus in animal experiments.
Category C: there was evidence of risk of adverse effects in animal reproduction studies, and no adequate evidence in human studies must take care of potential risks in pregnant women.
Category D: adequate data available with sufficient evidence of human fetal risk from various platforms, but despite the potential risk, and used only in emergency cases for potential benefits.
Category X: Drugs listed in this category outweigh the risks over benefits. Hence these categories of drugs need to be avoided by pregnant women.
Category N: There is no data available for the drug under this category
Pharmacology:
clomipramine is a tricyclic antidepressant drug used to treat depression, obsessive-compulsive disorder (OCD), and panic disorder.
Pharmacodynamics:
It works by increasing the levels of certain neurotransmitters, such as serotonin, in the brain. clomipramine acts as a reuptake inhibitor for serotonin, norepinephrine, and to a lesser extent, dopamine, which enhances the activity of these neurotransmitters in the brain. It is absorbed well orally and is metabolized in the liver. Common side effects of clomipramine include dry mouth, blurred vision, constipation, and drowsiness. It may also have anticholinergic effects.
Pharmacokinetics:
Absorption
clomipramine is absorbed well from the gastrointestinal tract, with peak plasma concentrations achieved within 2-6 hours after oral administration. The drug has a high bioavailability, which means that it is easily absorbed and utilized by the body.
Distribution
clomipramine is distributed throughout the body and is highly bound to plasma proteins. It has a large volume of distribution, which means that it spreads out throughout the body after being absorbed into the bloodstream.
Metabolism
clomipramine is metabolized in the liver, primarily through the cytochrome P450 system. The drug is metabolized into several active and inactive metabolites, which are then eliminated from the body through the kidneys.
Elimination and Excretion
clomipramine is eliminated from the body primarily through the kidneys, with only a small amount eliminated through the feces. The half-life of the drug is approximately 24 hours, which means that it takes about 24 hours for half of the drug to be eliminated from the body.
Administration:
Oral administration
clomipramine is an antidepressant medication typically used to treat depression and obsessive-compulsive disorder (OCD). It is available in oral tablet form and is usually taken once or twice a day, with or without food.
The recommended starting dose is 25mg per day, with gradual increases up to a maximum of 250mg per day. The dosage will be adjusted based on the individual’s response and tolerance to the medication.
Patient information leaflet
Generic Name: clomipramine
Why do we use clomipramine?
clomipramine is a tricyclic antidepressant medication used to treat depression and obsessive-compulsive disorder (OCD).
Depression is a mental disorder characterized by persistent feelings of sadness, hopelessness, and lack of interest in activities. clomipramine helps to improve mood and reduces symptoms of depression by increasing levels of neurotransmitters, such as serotonin and norepinephrine, in the brain.